CTMA is a service company specialized in the field of clinical research.
It has developed and uses a completely innovative, highly value added solution to facilitate patient recruitment in clinical trials by increasing the early recognition of potentially eligible patients by doctors.
CTMA was created in partnership with leading international industrial and academic clinical trials experts and software solutions specialists.
Its clients are mainly pharmaceutical companies and CROs (Contract Research Organization) but also include academic centers (scientific ‘societies’) who support the conduct of clinical trials internationally and in all areas of medicine.
Successfully audited by major international pharmaceutical companies, it has obtained the BPRA (Business Partner Risk Assessment) and the FTO (Freedom To Operate). The PCT (Patent Cooperation Treaty) is pending.